Cancer Rop Co. Ltd.

Dx & Vx Co., Ltd. develops and sells bio-health care products and provides molecular genetic testing services, primarily in South Korea. Its offerings include healthcare products such as Ofmom Carefree, oat fermented food, and biocleaners; diagnostic products including CLIDEX, precision diagnostics, and in vitro diagnostic kits; health check services; CDx development services; medical data; and funeral home operation services. The company also provides a bacterial vaccine for respiratory disease, a macular degeneration drug, atopy dermatitis drugs, xerophthalmia drugs, an anticancer vaccine, and new antibody drugs. Its pipeline includes an oral pediatric Covid-19/influenza vaccine, a new anti-cancer antibody drug, an antibody drug utilizing advanced mRNA vaccine development technique, a Vx Microbiome R&D pipeline, and the Oxford Vacmedix Vaccine, an anti-cancer vaccine utilizing ROP technology. It has research collaborations with bereum, Bioapp, CORESTEMCHEMON, Genscript PROBIO, JOINTOWN PHARMACEUTICAL GROUP, and others. The company was formerly known as Cancer Rop Co., Ltd. and changed its name to Dx & Vx Co., Ltd. in January 2022. It was founded in 2001 and is based in Seoul, South Korea.